RRM2B

Chr 8ARAD

ribonucleotide reductase regulatory TP53 inducible subunit M2B

Also known as: MTDPS8A, MTDPS8B, P53R2, RCDFRD

This gene encodes the small subunit of a p53-inducible ribonucleotide reductase. This heterotetrameric enzyme catalyzes the conversion of ribonucleoside diphosphates to deoxyribonucleoside diphosphates. The product of this reaction is necessary for DNA synthesis. Mutations in this gene have been associated with autosomal recessive mitochondrial DNA depletion syndrome, autosomal dominant progressive external ophthalmoplegia-5, and mitochondrial neurogastrointestinal encephalopathy. Alternatively spliced transcript variants have been described.[provided by RefSeq, Feb 2010]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismAR/ADLOEUF 0.704 OMIM phenotypes
Clinical SummaryRRM2B
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
45 unique Pathogenic / Likely Pathogenic· 195 VUS of 468 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available
📖
GeneReview available — RRM2B
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.70LOEUF
pLI 0.002
Z-score 2.58
OE 0.39 (0.230.70)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
1.21Z-score
OE missense 0.75 (0.650.86)
137 obs / 182.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.39 (0.230.70)
00.351.4
Missense OE?0.75 (0.650.86)
00.61.4
Synonymous OE?0.86
01.21.6
LoF obs/exp: 8 / 20.7Missense obs/exp: 137 / 182.9Syn Z: 0.84
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveRRM2B-related mitochondrial depletion syndromeLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.82top 10%
GOF
0.76top 25%
LOF
0.1895th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Literature Evidence

DNWe conclude that dominant-negative or gain-of-function mutations in RRM2B are a cause of multiple mtDNA deletions and adPEO.1
GOFWe conclude that dominant-negative or gain-of-function mutations in RRM2B are a cause of multiple mtDNA deletions and adPEO.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 19664747

ClinVar Variant Classifications

468 submitted variants in ClinVar

Classification Summary

Pathogenic17
Likely Pathogenic28
VUS195
Likely Benign119
Benign54
Conflicting31
17
Pathogenic
28
Likely Pathogenic
195
VUS
119
Likely Benign
54
Benign
31
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
13
4
0
0
17
Likely Pathogenic
16
11
0
1
28
VUS
4
134
55
2
195
Likely Benign
0
5
60
54
119
Benign
1
2
48
3
54
Conflicting
31
Total3415616360444

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

41 pathogenic / likely-pathogenic (of 48) ClinVar copy-number / structural variants overlap RRM2B — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

RRM2B · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.